Two Different Initial Treatment Regimens of Ranibizumab in Myopic Choroidal Neovascularization: 12-Month Results From a Randomized Controlled Study

Clinical and Experimental Ophthalmology - United Kingdom
doi 10.1111/ceo.13424

Related search